AUTHORS

Real Money authors - Timothy Collins

Timothy Collins

Timothy Collins has worked as a financial adviser since 1999, focusing on portfolio customization, with a concentration on correlation arbitrage and risk-managed growth. He started Collins Capital Advisors in 2007, which has evolved into TangleTrade Management, LLC. Currently, he operates Retro Wall Street, a site focused on education, trader mentoring and humor. You'll find him spending his days in the Retro Wall Street chat room.

 

Prior to joining his first firm, American Express Financial Advisors, in 1999, Collins worked as a staff accountant for United Information Systems in Bethesda, Md. He has also worked as a financial analyst for Securities Pricing and Research in Annapolis, Md. Collins is a graduate of McDaniel College (formerly Western Maryland College), with degrees in business administration, economics and sociology and is a winner of the Bates Prize.
Email Timothy Collins

Recent Articles By The Author

Here's Why I'm Making a Move on Vertiv Holdings

A familiar pattern has emerged potentially signally a 15% breakout from the current print.

I Find Everi Digital's Continued Revenue Expansion Intriguing

The parabolic stop-and-reverse has flipped bullish, so momentum and trend continue to favor the bulls. Here's how I'm trading it.

My Bet Is on JetBlue

As the transports start to take off and tech looks to have too much baggage, JBLU appears ready for the runway.

I See an 'Opendoor' to a Special Investment Strategy

Let's look at the trading opportunities offered by special purpose acquisition companies -- or SPACs.

I'm Ready to Unlock a Trade in Li Auto

While implied volatility looks like a bumpy ride ahead for LI, here's how I would approach this new Chinese name in the electric vehicle industry.

The Truck Stops Here: Why I'd Steer Clear of Nikola, GM

A new report, plus some odd Twitter behavior by the electric vehicle company's CEO, would have me backing away from the both auto names for now.

This Biotech Appears to Have the Right Formula for Investors

After reviewing the rally, let's zero in on one biotech name, Genprex, and where it appears to be going.

Is Nautilus Getting in Shape for a Run?

A potentially attractive trade idea based on past observations on Citron long calls.

An Options Play on the GM/Nikola Partnership

This Nikola tie-up could signal the start of a renaissance for GM.

Learn From My Pain the Perils of the Antiquated, Unfair Options Settlement Game

The timing mechanism of when options trades are settled works against the little guy and can prove very costly, as this author found out.

Email sent

Thank you, your email to has been sent successfully.

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight